These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 39043182)

  • 1. Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretation.
    Gilbert MA; Keefer-Jacques E; Jadhav T; Antfolk D; Ming Q; Valente N; Shaw GT; Sottolano CJ; Matwijec G; Luca VC; Loomes KM; Rajagopalan R; Hayeck TJ; Spinner NB
    Am J Hum Genet; 2024 Aug; 111(8):1656-1672. PubMed ID: 39043182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.
    Gilbert MA; Bauer RC; Rajagopalan R; Grochowski CM; Chao G; McEldrew D; Nassur JA; Rand EB; Krock BL; Kamath BM; Krantz ID; Piccoli DA; Loomes KM; Spinner NB
    Hum Mutat; 2019 Dec; 40(12):2197-2220. PubMed ID: 31343788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Very Rare
    Ferrandino M; Cardiero G; Di Dato F; Cerrato Y; Vitagliano L; Mandato C; Morisco F; Spagnuolo MI; Iorio R; Di Taranto MD; Fortunato G
    Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
    Andersson ER; Chivukula IV; Hankeova S; Sjöqvist M; Tsoi YL; Ramsköld D; Masek J; Elmansuri A; Hoogendoorn A; Vazquez E; Storvall H; Netušilová J; Huch M; Fischler B; Ellis E; Contreras A; Nemeth A; Chien KC; Clevers H; Sandberg R; Bryja V; Lendahl U
    Gastroenterology; 2018 Mar; 154(4):1080-1095. PubMed ID: 29162437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of cryptic JAG1 splice variants as a cause of Alagille syndrome and performance evaluation of splice predictor tools.
    Keefer-Jacques E; Valente N; Jacko AM; Matwijec G; Reese A; Tekriwal A; Loomes KM; Spinner NB; Gilbert MA
    HGG Adv; 2024 Oct; 5(4):100351. PubMed ID: 39244638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characterization of Alagille Syndrome in Patients with Cholestatic Liver Disease.
    Semenova N; Kamenets E; Annenkova E; Marakhonov A; Gusarova E; Demina N; Guseva D; Anisimova I; Degtyareva A; Taran N; Strokova T; Zakharova E
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated aneurysmal disease as an underestimated finding in individuals with JAG1 pathogenic variants.
    Rodrigues Bento J; Krebsová A; Van Gucht I; Valdivia Callejon I; Van Berendoncks A; Votypka P; Luyckx I; Peldova P; Laga S; Havelka M; Van Laer L; Trunecka P; Boeckx N; Verstraeten A; Macek M; Meester JAN; Loeys B
    Hum Mutat; 2022 Dec; 43(12):1824-1828. PubMed ID: 35819173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome sequencing increases diagnostic yield in clinically diagnosed Alagille syndrome patients with previously negative test results.
    Rajagopalan R; Gilbert MA; McEldrew DA; Nassur JA; Loomes KM; Piccoli DA; Krantz ID; Conlin LK; Spinner NB
    Genet Med; 2021 Feb; 23(2):323-330. PubMed ID: 33077891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel
    Micaglio E; Andronache AA; Carrera P; Monasky MM; Locati ET; Pirola B; Presi S; Carminati M; Ferrari M; Giamberti A; Pappone C
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined genetic analyses can achieve efficient diagnostic yields for subjects with Alagille syndrome and incomplete Alagille syndrome.
    Ohashi K; Togawa T; Sugiura T; Ito K; Endo T; Aoyama K; Negishi Y; Kudo T; Ito R; Saitoh S
    Acta Paediatr; 2017 Nov; 106(11):1817-1824. PubMed ID: 28695677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis in an adult patient with tetralogy of Fallot diagnosed with incomplete Alagille syndrome.
    Ponikowska M; Pollak A; Kotwica-Strzalek E; Brodowska-Kania D; Mosakowska M; Ploski R; Niemczyk S
    BMC Med Genet; 2020 Oct; 21(1):195. PubMed ID: 33008311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene.
    Cunningham D; Stanberry I; Ye S; Alonzo M; Zhao MT; Garg V; Lilly B
    Stem Cell Res; 2023 Sep; 71():103177. PubMed ID: 37549562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an induced pluripotent stem cell line NCHi011-A from a 23-year-old female with Alagille Syndrome harboring a heterozygous JAG1 pathogenic variant.
    Stanberry I; Cunningham D; Ye S; Alonzo M; Zhao MT; Garg V; Lilly B
    Stem Cell Res; 2023 Oct; 72():103213. PubMed ID: 37774637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining pathogenicity of NOTCH2 variants for diagnosis of Alagille syndrome type 2 using a large cohort of patients.
    Li ZD; Abuduxikuer K; Wang L; Hao CZ; Zhang J; Wang MX; Li LT; Qiu YL; Xie XB; Lu Y; Wang JS
    Liver Int; 2022 Aug; 42(8):1836-1848. PubMed ID: 35567760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alagille syndrome caused by NOTCH2 mutation presented atypical pathological changes.
    ShenTu Y; Mi X; Tang D; Jiang Y; Gao L; Ma X; Zhou B; Yang W; Shi J; Lan D; Chen G; Gong L
    Clin Chim Acta; 2021 Oct; 521():258-263. PubMed ID: 34332988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Alagille syndrome derived induced pluripotent stem cell line carrying heterozygous mutation in the JAGGED-1 gene at splicing site (Chr20: 10,629,709C>A) before exon 11.
    Zhu W; Cheng YS; Xu M; Farkhondeh A; Beers J; Zou J; Liu C; Baumgaertel K; Rodems S; Zheng W
    Stem Cell Res; 2021 May; 53():102366. PubMed ID: 34087995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene.
    Hatim O; Pavlinov I; Xu M; Linask K; Beers J; Liu C; Baumgärtel K; Gilbert M; Spinner N; Chen C; Zou J; Zheng W
    Stem Cell Res; 2023 Dec; 73():103231. PubMed ID: 37890331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
    McCright B; Lozier J; Gridley T
    Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Target gene sequence capture and next generation sequencing technology to diagnose four children with Alagille syndrome].
    Gao ML; Zhong XM; Ma X; Ning HJ; Zhu D; Zou JZ
    Zhonghua Er Ke Za Zhi; 2016 Jun; 54(6):441-5. PubMed ID: 27256232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel JAG1 frameshift variant causing Alagille syndrome with incomplete penetrance.
    Yang Y; Wang H
    Clin Biochem; 2022 Jun; 104():19-21. PubMed ID: 35151641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.